Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2013
05/10/2013WO2012178015A3 Lrrk2 inhibitors
05/10/2013WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
05/10/2013WO2012124311A8 Novel phenylpyridine derivative and drug containing same
05/10/2013CA2853967A1 8-fluorophthalazin-1 (2h) -one compounds as inhibitors of btk activity
05/10/2013CA2853439A1 Benzenesulfonamide compounds and their use as therapeutic agents
05/10/2013CA2852700A1 Rod-like hepatitis c virus inhibitors containing the fragment {2-[4-(biphenyl-4-yl)-1h-imidazo-2-yl]pyrrolidine-1-carbonlymethyl}amine
05/10/2013CA2849945A1 New aryl-quinoline derivatives
05/09/2013US20130116444 Process for cabazitaxel, and intermediates thereof
05/09/2013US20130116430 Novel nicotinamide derivative or salt thereof
05/09/2013US20130116288 Selective Androgen Receptor Modulators
05/09/2013US20130116287 Fungicide hydroximoyl-heterocycles derivatives
05/09/2013US20130116246 8-fluorophthalazin-1(2h)-one compounds
05/09/2013US20130116240 Indole compounds and pharmaceutical use thereof
05/09/2013US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
05/09/2013US20130116234 Aryl-quinoline derivatives
05/09/2013US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors
05/09/2013US20130116229 Novel inhibitor compounds of phosphodiesterase type 10a
05/09/2013US20130116216 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
05/09/2013US20130116214 Heterocyclic ring compound
05/09/2013US20130115314 Compounds Useful as Inhibitors of ATR Kinase
05/09/2013US20130115313 Compounds Useful as Inhibitors of ATR Kinase
05/09/2013US20130115312 Compounds Useful as Inhibitors of ATR Kinase
05/09/2013US20130115310 Compounds Useful as Inhibitors of ATR Kinase
05/09/2013US20130115194 Hepatitis c virus inhibitors
05/09/2013US20130115193 Hepatitis C Virus Inhibitors
05/09/2013US20130113367 Heterocyclic compound and organic light-emitting device including the same
05/08/2013EP2589600A1 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
05/08/2013EP2588476A1 Synthesis and use of kinase inhibitors
05/08/2013EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
05/08/2013EP2588467A1 Heterocyclic compounds and their use as inhibitors of pi3k activity
05/08/2013EP2588465A1 Sgc stimulators
05/08/2013EP2588455A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
05/08/2013EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders
05/08/2013CN103097380A Inhibitor of casein kinase 1[delta] and casein kinase 1[epsilon]
05/08/2013CN103097379A Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them
05/08/2013CN103097376A Pyridine compounds for controlling invertebrate pests ii
05/08/2013CN103097375A Cyclohexyl-azetidinyl antagonists of CCR2
05/08/2013CN103097354A Substituted benzamide compounds
05/08/2013CN103097352A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/08/2013CN103087054A 4-pyridyl phenyl ether compounds, and preparation method and application thereof
05/08/2013CN103087053A Preparation of oxadiazole compound and application thereof to anti-inflammatory treatment
05/08/2013CN103087045A Benzimidazole heterocyclic compound, pharmaceutical composition and application thereof
05/08/2013CN103087044A Method for preparing benzimidazole heterocyclic compound
05/08/2013CN103086981A New compounds
05/08/2013CN103086953A Heterocyclic compound and organic light-emitting device including the same
05/08/2013CN103086931A Novel method of preparing iloperidone
05/08/2013CN102174031B 1,2,3-thiadiazole-1,3,4-thiadiazole compounds and preparation method and application thereof
05/08/2013CN102015635B 氮杂环丁烷衍生物 Azetidine derivatives
05/08/2013CN101970430B Novel pyrimidine derivatives
05/08/2013CN101827830B Insecticidal compounds
05/08/2013CN101663297B Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (s1p) agonists
05/08/2013CN101454308B Process for preparing heterocyclic derivatives
05/08/2013CN101218224B Compounds and methods for the treatment or prevention of flavivirus infections
05/08/2013CN101203509B Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
05/07/2013US8436344 Organic electroluminescent device
05/07/2013US8436008 Substituted heterocyclic compounds
05/07/2013US8435989 Processes for the preparation of rivaroxaban and intermediates thereof
05/07/2013US8435988 Benzimidazole derivatives as P13 kinase inhibitors
05/07/2013US8435986 Bicyclic traizole derivatives for treating of tumors
05/07/2013US8435985 Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
05/07/2013CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
05/07/2013CA2598460C Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
05/07/2013CA2575081C Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
05/07/2013CA2538864C Thalidomide analogs as tnf-alpha modulators
05/07/2013CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
05/02/2013WO2013063458A2 Inhibiting g protein coupled receptor 6 kinase polypeptides
05/02/2013WO2013063012A1 Myxovirus therapeutics, compounds, and uses related thereto
05/02/2013WO2013062843A1 Pyridine- sulfoximines as tyrosine kinase inhibitors
05/02/2013WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative
05/02/2013WO2013062027A1 Azole derivative
05/02/2013WO2013061973A1 Heteroaryl sulfonamide compound or salt thereof
05/02/2013WO2013061962A1 Bicyclic compound
05/02/2013WO2013061297A1 Pyridazine Derivatives Useful in Therapy
05/02/2013WO2013061081A1 Anticancer benzopyrazines via the inhibition of fgfr kinases
05/02/2013WO2013061074A1 Quinolines as fgfr kinase modulators
05/02/2013WO2013061005A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/02/2013WO2013060751A1 Novel pyrazine derivatives
05/02/2013WO2013060744A2 Compounds having an ethr inhibiting activity - use of said compounds as drugs - pharmaceutical composition and product containing said compounds
05/02/2013WO2013060098A1 Kinase inhibitor and method for treatment of related diseases
05/02/2013WO2013059928A1 Hiv protease inhibitors
05/02/2013WO2013015661A3 Novel prodrugs of 5-(2,4-dihydroxy-5-isopropylphenyl)-n-ethyl-4-(5-methyl1-1,2,4-oxadiazol-3-yl)isoxazole-3-carboxamide
05/02/2013US20130109854 Novel Methods for Preparation of (+)-1-ethyl-4-[2-(4-morpholinyl)ethyl)-3,3-diphenyl-2-pyrrolidinone and Salts Thereof
05/02/2013US20130109853 Preparation method of 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3(s)-4-fluorophenyl-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazole-3-one
05/02/2013US20130109698 Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein
05/02/2013US20130109690 Novel crystalline forms of (3r, 6r)-3-(2,3-dihydro-1h-inden-2-yl)-1-[(1r)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1s)-1-methylpropyl]-2,5-piperazinedione
05/02/2013US20130109689 Novel Methods for Preparation of (+)-1-ethyl-4-[2-(4-morpholinyl)ethyl)-3,3-diphenyl-2-pyrrolidinone
05/02/2013US20130109685 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
05/02/2013US20130109683 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
05/02/2013US20130109678 Radioprotector compounds and methods
05/02/2013US20130109676 Oxadiazole Diaryl Compounds
05/02/2013US20130109670 Triazine compounds as pi3 kinase and mtor inhibitors
05/02/2013US20130109669 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
05/02/2013US20130109666 Methods for treating post traumatic stress disorder
05/02/2013US20130109665 Novel pyrazine derivatives
05/02/2013US20130109660 Novel pyrimidinecarboxamide derivatives
05/02/2013US20130109653 Substituted Pyridine Compound
05/02/2013US20130109652 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
05/02/2013US20130109566 Pesticidal compositions and processes related thereto
05/02/2013US20130108573 Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
05/02/2013CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 647